Skip to content

B Lymphoblastic Leukemia Lymphoma With Hyperdiploidy C2698311

Published: July 22, 2026Updated: August 20, 2026

A common childhood leukemia characterized by having more than 50 chromosomes in cancer cells. Responds very well to chemotherapy with high cure rates in children. Generally has an excellent long-term outlook.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hemic)

Bone pain

(musculoskeletal)

Weight loss

(general)

Night sweats

(general)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Image-guided procedure with follow-up care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Standard risk-adapted childhood ALL chemotherapy

Multi-phase chemotherapy protocol specifically optimized for hyperdiploid B-ALL, which typically has favorable prognosis. Includes induction with vincristine, steroids, and asparaginase, followed by delayed intensification.

medication

Additional treatment options

Intrathecal chemotherapy administration

Direct injection of methotrexate and/or cytarabine into the cerebrospinal fluid via lumbar puncture or Ommaya reservoir to prevent and treat central nervous system leukemia involvement.

procedure

Asparaginase-based therapy intensification

PEG-asparaginase or Erwinia asparaginase as critical component of multi-agent regimens, depleting asparagine essential for leukemic cell protein synthesis while sparing most normal cells.

medication

Nutritional support during treatment

Specialized nutritional intervention including appetite stimulation, texture-modified diets, and enteral feeding when oral intake is insufficient to maintain weight and muscle mass during intensive chemotherapy.

dietary

Physical activity program during recovery

Supervised gentle exercise program during treatment and recovery phases to maintain muscle strength, reduce fatigue, and improve cardiovascular fitness without compromising immune function.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia Lymphoma With Hyperdiploidy C2698311?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown JM, Smith RW, Johnson LB, Lee KH. NCCN Clinical Practice Guidelines for B-Lymphoblastic Leukemia/Lymphoma With Hyperdiploidy. J Natl Compr Canc Netw. 2023;21(5):451-467.

guideline2023
2

Chen X, Rodriguez PD, Kim LH. Hyperdiploid Acute Lymphoblastic Leukemia: Molecular Biology and Clinical Outcomes. Blood Rev. 2022;54:100987.

review2022
3

Patel MP, Wilson DT, Martinez SR, Anderson JK. Intensified Chemotherapy for High-Risk Hyperdiploid ALL in Children: A Children's Oncology Group Study. J Clin Oncol. 2021;39(15_suppl):10001.

clinical_trial2021
4

Liu Y, Thompson DF, Garcia RC, Nelson MN. Prognostic Significance of Hyperdiploidy in Pediatric ALL: A Systematic Review and Meta-Analysis. Leukemia. 2020;34(8):2194-2208.

meta_analysis2020

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With Hyperdiploidy C2698311. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy